Showing results (1361-1370 of 1,689) with videos related to

Sort By:
Pageof 169
Journal of General Internal Medicine|January 10, 2023
Screen Time from Adolescence to Adulthood and Cardiometabolic Disease: a Prospective Cohort StudyJason M Nagata, Christopher M Lee, Feng Lin, et al.
Cultural Diversity & Ethnic Minority Psychology|March 3, 2004
Person factors associated with suicidal behavior among African American women and menNadine J Kaslow, Ann Webb Price, Sarah Wyckoff, et al.
The Medical Journal of Australia|November 18, 1991
Cardiac risk factor management. Experience of an outpatient hypertension clinicN E Straznicky, L G Howes, H Krum, et al.
Current Issues in Molecular Biology|November 26, 2024
Evidence to Support the Collaboration of SP1, MYC, and HIF1A and Their Association with microRNAsJong Ho Chun, Kotohiko Kimura, Monika Rajput, et al.
Journal of Acquired Immune Deficiency Syndromes|April 1, 1994
A phase I/II trial of intravenous L-2-oxothiazolidine-4-carboxylic acid (procysteine) in asymptomatic HIV-infected subjectsR C Kalayjian, G Skowron, R T Emgushov, et al.
American Journal of Public Health|September 4, 1999
Fruit and vegetable consumption and prevention of cancer: the Black Churches United for Better Health projectM K Campbell, W Demark-Wahnefried, M Symons, et al.
Applied and Environmental Microbiology|September 11, 2007
Metagenomic and small-subunit rRNA analyses reveal the genetic diversity of bacteria, archaea, fungi, and viruses in soilNoah Fierer, Mya Breitbart, James Nulton, et al.
The Review of Scientific Instruments|June 3, 2019
A six-degree-of-freedom micro-vibration acoustic isolator for low-temperature radiation detectors based on superconducting transition-edge sensorsL Gottardi, H van Weers, J Dercksen, et al.
The Journal of Infectious Diseases|May 24, 2001
Analysis of human immunodeficiency virus type 1 drug resistance in children receiving nucleoside analogue reverse-transcriptase inhibitors plus nevirapine, nelfinavir, or ritonavir (Pediatric AIDS Clinical Trials Group 377)S H Eshleman, P Krogstad, J B Jackson, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 15, 2000
Safety, tolerability, and antiretroviral effects of ritonavir-nelfinavir combination therapy administered for 48 weeksC P Raines, C Flexner, E Sun, et al.
Pageof 169